Dr Xin Wei Wang

      

Dr Xin Wei Wang

Associate Editor: Xin Wang

Dr. Wang is a Senior Investigator at the National Cancer Institute (NCI) where he oversees a basic/translational research program emphasizing new molecular approaches to define tumor subtypes and identify biomarkers for early detection, diagnosis, prognosis and prediction, to delineate the molecular mechanisms of liver cancer with applications towards precision medicine. Dr. Wang received his PhD training from New York University School of Medicine and further research training from Roche Institute of Molecular Biology and NCI. Currently, he also serves as Chief of the Liver Carcinogenesis Section and Deputy Chief of the Laboratory of Human Carcinogenesis, Center for Cancer Research at NCI. He is a world renowned liver cancer researcher with a special focus on cancer functional genomics. His lab utilizes state-of-the-art technologies to study liver cancer and other human malignancies. He leads several major international research initiatives on liver cancer genomics and clinical studies through collaborations with multiple universities and cancer centers. He is Honorary Professor of Fudan University and a recipient of several NIH Director’s Awards and NCI Director’s Awards for his outstanding scientific achievement in liver cancer research. He also is a recipient of the NCI Mentor’s Award for excellence in mentoring and guiding the careers of trainees in cancer research and Blue Faery Award for excellence in liver cancer research.